These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1321101)

  • 1. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
    Moerlein SM; Banks WR; Parkinson D
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
    Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ
    Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
    Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
    Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
    Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
    Int J Rad Appl Instrum B; 1991; 18(8):871-81. PubMed ID: 1839303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical synthesis of [18F]fluororaclopride.
    Kiesewetter DO; Brücke T; Finn RD
    Int J Rad Appl Instrum A; 1989; 40(6):455-60. PubMed ID: 2551844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography.
    Moerlein SM; Laufer P; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Eur J Nucl Med; 1986; 12(4):211-6. PubMed ID: 2876896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
    Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
    Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
    Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
    J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
    Halldin C; Högberg T; Farde L
    Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.